<DOC>
	<DOC>NCT01015404</DOC>
	<brief_summary>This study aims to investigate the safety in using Trafermin (recombinant human basic fibroblast growth factor) with periodontal surgery.</brief_summary>
	<brief_title>A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Vertical intrabony defect from radiographs at baseline Age of 20 years or older Using an investigational drug within the past 24 months Coexisting malignant tumour or history of the same Coexisting diabetes (HbA1C 6.5% or more) Taking bisphosphonates Coexisting gingival overgrowth or history of the same</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Trafermin</keyword>
	<keyword>Periodontitis</keyword>
</DOC>